Ex vivo Assays in MM Primary Patient Samples
Vivia Biotech can
identify the best drugs
for MM patient
enhancing your MM
drug profiling
processes thanks to
our improved and
novel assays and to
the access to
biological samples
from real patients
- Vivia Biotech has access to primary samples from patients diagnosed with a variety of hematological malignancies including MM and can provide extremely valuable data making the difference in your drug development pipeline.
MM Patient Samples Availability & Experience in MM
Vivia MM assays in a nutshell…
We have specific assays to cover the different mechanisms of action of many drugs and compounds and to capture the effects of apoptosis, proliferation, T-Cell Engagers, T or NK immune cell modulation, antibody-dependent cellular cytotoxicity or complement dependent cytotoxicity between others and its selectivity, directly on fresh MM patient samples.
Our key innovations supply sound pharmacology using real MM patient samples.
Vivia's peer-reviewed published MM data
